Dermal Fillers
OLIDIA references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 10971
Olidia 365
In stock
Volume
1 x 365 mg
Laboratory
PRP Life Science Co., Ltd.
Origin
South Korea
Indication
Severe facial wrinkles and folds, volume defects, facial lipoatrophy, facial contour deformities
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
Olidia 365 - also known as Olidia 365MG or Olidia PLLA 365MG - is an injectable PLLA-based dermal filler from the OLIDIA brand (manufacturer PRP Life Science Co., Ltd., South Korea), designed for deep dermal use to support the correction of severe facial wrinkles, volume defects, facial lipoatrophy, and facial contour improvement. The formula contains 365 mg of poly-L-lactic acid with carboxymethylcellulose and mannitol, intended for treatment in the subcutaneous layer. Olidia 365 is supplied as a sterile absorbable PLLA dermal filler in a single vial, reconstituted with sterile water for injection to approximately 5 mL prior to use.
Key Benefits of Olidia 365
- Supports correction of severe facial wrinkles and folds
- Helps replace volume defects
- Supports improvement of facial lipoatrophy
- Helps improve facial contour deformities
- PLLA-based formulation designed for a gradual tissue response after injection
Indications and Professional Use
Main indications
- Severe facial wrinkles and folds
- Volume defects
- Facial lipoatrophy
- Facial contour deformities
Professional use
Olidia 365 is intended strictly for professional use by qualified aesthetic practitioners, injected into the subcutaneous layer / deep dermis. Reconstitution requires an 18G needle to add approximately 5 mL of sterile water, per multiple independent sources. For injection, gauge reports differ between sources: a document purporting to be the manufacturer's own IFU reports a 26G cannula or needle, while a separate reseller reports a 23G, 50mm blunt cannula.
Treatment areas
- Face (general application per the KB article).
Patient profile
Do not use in patients with acute or chronic skin disease, infection, or inflammation at or near the injection site. Do not use in patients sensitive to the product or its components. Do not use in patients with susceptibility to excessive scarring or keloids. Do not use in patients with a history of herpetic eruption. Do not use in patients with liver or blood coagulation malfunction.
How Olidia 365 Works
Olidia 365 works through poly-L-lactic acid (PLLA) microparticles that stimulate a gradual tissue response after injection into the subcutaneous layer. This supports correction of severe facial wrinkles and folds, replacement of volume defects, improvement of facial lipoatrophy, and correction of facial contour deformities over time.
Why Order From Allpara
Allpara offers genuine, verified OLIDIA products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
Is Olidia 365MG suitable for facial lipoatrophy?
Yes. Olidia 365 is indicated for the treatment of severe facial wrinkles and folds, volume defects, facial lipoatrophy, and facial contour deformities.
What is in the Olidia PLLA 365MG formula?
Olidia 365 contains 365 mg of poly-L-lactic acid (PLLA) with carboxymethylcellulose and mannitol, per the manufacturer.
Is Olidia 365MG CE-marked?
Yes. Olidia 365 is CE-marked, per the manufacturer.
How is Olidia 365 supplied?
Olidia 365 is supplied as 1 vial containing 365 mg of PLLA, reconstituted with sterile water for injection to approximately 5 mL prior to use.
More from PRP Life Science
Clinic alternatives
Collagen Stimulators
/ Recently viewed
Pick up where you left off
Olidia 365
In stock
CE Marked
Olidia 365 - also known as Olidia 365MG or Olidia PLLA 365MG - is an injectable PLLA-based dermal filler from the OLIDIA brand (manufacturer PRP Life Science Co., Ltd., South Korea), designed for deep dermal use to support the correction of severe facial wrinkles, volume defects, facial lipoatrophy, and facial contour improvement. The formula contains 365 mg of poly-L-lactic acid with carboxymethylcellulose and mannitol, intended for treatment in the subcutaneous layer. Olidia 365 is supplied as a sterile absorbable PLLA dermal filler in a single vial, reconstituted with sterile water for injection to approximately 5 mL prior to use.
Key Benefits of Olidia 365
- Supports correction of severe facial wrinkles and folds
- Helps replace volume defects
- Supports improvement of facial lipoatrophy
- Helps improve facial contour deformities
- PLLA-based formulation designed for a gradual tissue response after injection
Indications and Professional Use
Main indications
- Severe facial wrinkles and folds
- Volume defects
- Facial lipoatrophy
- Facial contour deformities
Professional use
Olidia 365 is intended strictly for professional use by qualified aesthetic practitioners, injected into the subcutaneous layer / deep dermis. Reconstitution requires an 18G needle to add approximately 5 mL of sterile water, per multiple independent sources. For injection, gauge reports differ between sources: a document purporting to be the manufacturer's own IFU reports a 26G cannula or needle, while a separate reseller reports a 23G, 50mm blunt cannula.
Treatment areas
- Face (general application per the KB article).
Patient profile
Do not use in patients with acute or chronic skin disease, infection, or inflammation at or near the injection site. Do not use in patients sensitive to the product or its components. Do not use in patients with susceptibility to excessive scarring or keloids. Do not use in patients with a history of herpetic eruption. Do not use in patients with liver or blood coagulation malfunction.
How Olidia 365 Works
Olidia 365 works through poly-L-lactic acid (PLLA) microparticles that stimulate a gradual tissue response after injection into the subcutaneous layer. This supports correction of severe facial wrinkles and folds, replacement of volume defects, improvement of facial lipoatrophy, and correction of facial contour deformities over time.
Why Order From Allpara
Allpara offers genuine, verified OLIDIA products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
Is Olidia 365MG suitable for facial lipoatrophy?
Yes. Olidia 365 is indicated for the treatment of severe facial wrinkles and folds, volume defects, facial lipoatrophy, and facial contour deformities.
What is in the Olidia PLLA 365MG formula?
Olidia 365 contains 365 mg of poly-L-lactic acid (PLLA) with carboxymethylcellulose and mannitol, per the manufacturer.
Is Olidia 365MG CE-marked?
Yes. Olidia 365 is CE-marked, per the manufacturer.
How is Olidia 365 supplied?
Olidia 365 is supplied as 1 vial containing 365 mg of PLLA, reconstituted with sterile water for injection to approximately 5 mL prior to use.
More from PRP Life Science
View laboratory →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.